摘要
目的 采用高聚生瘤体内注射配合放射治疗颈部淋巴结转移癌 ,观察其疗效、不良反应并与单纯放射治疗进行比较。 方法 6 0例患者采用高聚生瘤体内注射配合放射治疗为综合组 ,同期单纯接受放射治疗 6 0例患者作为对照组。 1 2 0例患者均接受60 Co体外照射 ,照射剂量DT6 5 70GY/ 6 5 7周完成疗程。综合组采用高聚生瘤体内注射 ,2次 /周、6 1 2次为 1个疗程。 结果 瘤体完全消退率 ,综合组为 88 33% (5 3/ 6 0 ) ,对照组为 70 % (4 2 / 6 0 ) ,两组比较有差异 (P <0 0 5 )。 结论 高聚生瘤体内注射 ,使瘤体内药物浓度增高 ,配合放射治疗、增强了对肿瘤细胞的杀伤作用 。
Objective To evaluate the curative effect of HASL plus radiotherapy in treatment of cervical lymph node metastatic carcinoma,and compare with radiotherapy Methods 120 patients were radomized into two groups:A and B group(60cases each).Both of them received radiotherapy 60 Co, 65~70GY,6 5~7 0 week.Moreover, A group was injected HASL into the metastatic lymph node,500~1500u biweekly,sum to 6~12times.Results CR of the metastatic lymph node was:A group 80 33%(53/60);B group 70%(42/60).There's obvious difference(P<0.05) Conclusion HASL combined with radiotherapy on cervical lymph node metastatic carcinoma is advantaged in clinical practice.
出处
《医药论坛杂志》
2004年第1期17-18,共2页
Journal of Medical Forum
关键词
高聚生
放射治疗
颈部淋巴结转移癌
不良反应
瘤体注射
cervical lymph node
metastatic carcinoma
radiotherapy
highly agglutinative staphylouoccin.
